Excess of free fatty acids as a cause of metabolic dysfunction in skeletal muscle

Physiological Research

Volumn 65, Issue 2, 2016, Pages 193-207

  Tumova, J ^a   Andel, M ^a   Trnka, J ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Free fatty acids; Insulin resistance; Mitochondrial function; Obesity; Skeletal muscle

Indexed keywords

FATTY ACID;

ADIPOSE TISSUE; ANIMAL; ENERGY METABOLISM; HUMAN; METABOLISM; OBESITY; PATHOLOGY; PHYSIOLOGY; SKELETAL MUSCLE;

ADIPOSE TISSUE; ANIMALS; ENERGY METABOLISM; FATTY ACIDS, NONESTERIFIED; HUMANS; MUSCLE, SKELETAL; OBESITY;

EID: 84975518492     PISSN: 08628408     EISSN: 18029973     Source Type: Journal    
DOI: 10.33549/physiolres.932993     Document Type: Review

References (111)

1. AMATI F, DUBÉ JJ, ALVAREZ-CARNERO E, EDREIRA MM, CHOMENTOWSKI P, COEN PM, SWITZER GE, BICKEL PE, STEFANOVIC-RACIC M, TOLEDO FG, GOODPASTER BH: Skeletal muscle triglycerides, diacylglycerols, and ceramides in insulin resistance: another paradox in endurance-trained athletes? Diabetes 60: 2588-2597, 2011.
2. 2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans. J Clin Invest 119: 573-581, 2009.
3. ANDERSSON A, NÄLSÉN C, TENGBLAD S, VESSBY B: Fatty acid composition of skeletal muscle reflects dietary fat composition in humans. Am J Clin Nutr 76: 1222-1229, 2002.
4. ANTUNA-PUENTE B, FEVE B, FELLAHI S, BASTARD JP. Adipokines: the missing link between insulin resistance and obesity. Diabetes Metab 34: 2-11, 2008.
5. ASTRUP A: Healthy lifestyles in Europe: prevention of obesity and type II diabetes by diet and physical activity. Public Health Nutr 4: 499-515, 2001.
6. BACHMANN OP, DAHL DB, BRECHTEL K, MACHANN J, HAAP M, MAIER T, LOVISCACH M, STUMVOLL M, CLAUSSEN CD, SCHICK F, HÄRING HU, JACOB S: Effects of intravenous and dietary lipid challenge on intramyocellular lipid content and the relation with insulin sensitivity in humans. Diabetes 50: 2579-2584, 2001.
7. BARBOSA MR, SAMPAIO IH, TEODORO BG, SOUSA TA, ZOPPI CC, QUEIROZ AL, PASSOS MA, ALBERICI LC, TEIXEIRA FR, MANFIOLLI AO, BATISTA TM, CAPPELLI AP, REIS RI, FRASSON D, KETTELHUT IC, PARREIRAS-E-SILVA LT, COSTA-NETO CM, CARNEIRO EM, CURI R, SILVEIRA LR: Hydrogen peroxide production regulates the mitochondrial function in insulin resistant muscle cells: effect of catalase overexpression. Biochim Biophys Acta 1832: 1591-1604, 2013.
8. BELFORT R, MANDARINO L, KASHYAP S, WIRFEL K, PRATIPANAWATR T, BERRIA R, DEFRONZO RA, CUSI K: Dose-response effect of elevated plasma free fatty acid on insulin signaling. Diabetes 54: 1640-1648, 2005.
9. BELL JA, REED MA, CONSITT LA, MARTIN OJ, HAYNIE KR, HULVER MW, MUOIO DM, DOHM GL: Lipid partitioning, incomplete fatty acid oxidation, and insulin signal transduction in primary human muscle cells:effects of severe obesity, fatty acid incubation, and fatty acid translocase/CD36 overexpression. J Clin Endocrinol Metab 95: 3400-3410, 2010.
10. BLOCH-DAMTI A, BASHAN N. Proposed mechanisms for the induction of insulin resistance by oxidative stress: Antioxid Redox Signal 7: 1553-1567, 2005.
11. BONEN A, PAROLIN ML, STEINBERG GR, CALLES-ESCANDON J, TANDON NN, GLATZ JF, LUIKEN JJ, HEIGENHAUSER GJ, DYCK DJ: Triacylglycerol accumulation in human obesity and type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport and increased sarcolemmal FAT/CD36:FASEB J 18: 1144-1146, 2004.
12. BONNARD C, DURAND A, PEYROL S, CHANSEAUME E, CHAUVIN MA, MORIO B, VIDAL H, RIEUSSET J:Mitochondrial dysfunction results from oxidative stress in the skeletal muscle of diet-induced insulin-resistant mice. J Clin Invest 118: 789-800, 2008.
13. BRAISSANT O, FOUFELLE F, SCOTTO C, DAUÇA M, WAHLI W: Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology 137: 354-366, 1996.
14. BRAND MD, NICHOLLS DG: Assessing mitochondrial dysfunction in cells: Biochem J 435: 297-312, 2011.
15. BRANDS M, HOEKS J, SAUERWEIN HP, ACKERMANS MT, OUWENS M, LAMMERS NM, VAN DER PLAS MN, SCHRAUWEN P, GROEN AK, SERLIE MJ: Short-term increase of plasma free fatty acids does not interfere with intrinsic mitochondrial function in healthy young men. Metabolism 60: 1398-1405, 2011.
16. BREHM A, KRSSAK M, SCHMID AI, NOWOTNY P, WALDHÄUSL W, RODEN M: Increased lipid availability impairs insulin-stimulated ATP synthesis in human skeletal muscle. Diabetes 55: 136-140, 2006.
17. BRUCE CR, HOY AJ, TURNER N, WATT MJ, ALLEN TL, CARPENTER K, COONEY GJ, FEBBRAIO MA, KRAEGEN EW: Overexpression of carnitine palmitoyltransferase-1 in skeletal muscle is sufficient to enhance fatty acid oxidation and improve high-fat diet-induced insulin resistance. Diabetes 58: 550-558, 2009.
18. CAMPBELL PJ, CARLSON MG, NURJHAN N: Fat metabolism in human obesity: Am J Physiol 266: E600-E605, 1994.
19. CHAVEZ JA, SUMMERS SA: Characterizing the effects of saturated fatty acids on insulin signaling and ceramide and diacylglycerol accumulation in 3T3-L1 adipocytes and C2C12 myotubes. Arch Biochem Biophys 419: 101-109, 2003.
20. COLL T, EYRE E, RODRÍGUEZ-CALVO R, PALOMER X, SÁNCHEZ RM, MERLOS M, LAGUNA JC, VÁZQUEZ-CARRERA M: Oleate reverses palmitate-induced insulin resistance and inflammation in skeletal muscle cells. J Biol Chem 283: 11107-11116, 2008.
21. COLL T, ALVAREZ-GUARDIA D, BARROSO E, GÓMEZ-FOIX AM, PALOMER X, LAGUNA JC, VÁZQUEZCARRERA M: Activation of peroxisome proliferator-activated receptor-(delta) by GW501516 prevents fatty acid-induced nuclear factor-(kappa)B activation and insulin resistance in skeletal muscle cells. Endocrinology 151: 1560-1569, 2010.
22. CRESSER J, BONEN A, CHABOWSKI A, STEFANYK LE, GULLI R, RITCHIE I, DYCK DJ: Oral administration of a PPAR-delta agonist to rodents worsens, not improves, maximal insulin-stimulated glucose transport in skeletal muscle of different fibers. Am J Physiol Regul Integr Comp Physiol 299: R470-R479, 2010.
23. DE FERRANTI S, MOZAFFARIAN D: The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences. Clin Chem 54: 945-955, 2008.
24. DEFRONZO RA, GUNNARSSON R, BJÖRKMAN O, OLSSON M, WAHREN J: Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus. J Clin Invest 76: 149-155, 1985.
25. DESPRÉS JP, LEMIEUX I: Abdominal obesity and metabolic syndrome. Nature 444: 881-887, 2006.
26. ECKARDT K, TAUBE A, ECKEL J: Obesity-associated insulin resistance in skeletal muscle: role of lipid accumulation and physical inactivity. Rev Endocr Metab Disord 12: 163-172, 2011.
27. ENOS RT, DAVIS JM, VELÁZQUEZ KT, MCCLELLAN JL, DAY SD, CARNEVALE KA, MURPHY EA: Influence of dietary saturated fat content on adiposity, macrophage behavior, inflammation, and metabolism:composition matters. J Lipid Res 54: 152-163, 2013.
28. ESSER N, LEGRAND-POELS S, PIETTE J, SCHEEN AJ, PAQUOT N: Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res Clin Pract 105: 141-150, 2014.
29. EVANS K, BURDGE GC, WOOTTON SA, CLARK ML, FRAYN KN: Regulation of dietary fatty acid entrapment in subcutaneous adipose tissue and skeletal muscle. Diabetes 51: 2684-2690, 2002.
30. FEDIUC S, GAIDHU MP, CEDDIA RB: Regulation of AMP-activated protein kinase and acetyl-CoA carboxylase phosphorylation by palmitate in skeletal muscle cells. J Lipid Res 47: 412-420, 2006.
31. FIELDING BA, CALLOW J, OWEN RM, SAMRA JS, MATTHEWS DR, FRAYN KN: Postprandial lipemia: the origin of an early peak studied by specific dietary fatty acid intake during sequential meals. Am J Clin Nutr 63:36-41, 1996.
32. FISHER-WELLMAN KH, WEBER TM, CATHEY BL, BROPHY PM, GILLIAM LA, KANE CL, MAPLES JM, GAVIN TP, HOUMARD JA, NEUFER PD: Mitochondrial respiratory capacity and content are normal in young insulin-resistant obese humans. Diabetes 63: 132-141, 2014.
33. FORMAN BM, CHEN J, EVANS RM: Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta. Proc Natl Acad Sci U S A 94: 4312-4317, 1997.
34. FRAYN KN: Adipose tissue as a buffer for daily lipid flux. Diabetologia 45: 1201-1210, 2002.
35. FURLER SM, COONEY GJ, HEGARTY BD, LIM-FRASER MY, KRAEGEN EW, OAKES ND: Local factors modulate tissue-specific NEFA utilization: assessment in rats using 3H-(R)-2-bromopalmitate. Diabetes 49:1427-1433, 2000.
36. GALGANI JE, MORO C, RAVUSSIN E: Metabolic flexibility and insulin resistance. Am J Physiol Endocrinol Metab 295: E1009-E1017, 2008.
37. GOODPASTER BH, HE J, WATKINS S, KELLEY DE: Skeletal muscle lipid content and insulin resistance: evidence for a paradox in endurance-trained athletes. J Clin Endocrinol Metab 86: 5755-5761, 2001.
38. GULBINS E: Regulation of death receptor signaling and apoptosis by ceramide. Pharmacol Res 47: 393-399, 2003.
39. HAN DH, HANCOCK CR, JUNG SR, HIGASHIDA K, KIM SH, HOLLOSZY JO: Deficiency of the mitochondrial electron transport chain in muscle does not cause insulin resistance. PLoS One 6: e19739, 2011.
40. HANCOCK CR, HAN DH, CHEN M, TERADA S, YASUDA T, WRIGHT DC, HOLLOSZY JO: High-fat diets cause insulin resistance despite an increase in muscle mitochondria. Proc Natl Acad Sci U S A 105: 7815-7820, 2008.
41. HEGARTY BD, COONEY GJ, KRAEGEN EW, FURLER SM: Increased efficiency of fatty acid uptake contributes to lipid accumulation in skeletal muscle of high fat-fed insulin-resistant rats. Diabetes 51: 1477-1484, 2002.
42. HENIQUE C, MANSOURI A, FUMEY G, LENOIR V, GIRARD J, BOUILLAUD F, PRIP-BUUS C, COHEN I:Increased mitochondrial fatty acid oxidation is sufficient to protect skeletal muscle cells from palmitateinduced apoptosis. J Biol Chem 285: 36818-36827, 2010.
43. HEVENER AL, HE W, BARAK Y, LE J, BANDYOPADHYAY G, OLSON P, WILKES J, EVANS RM, OLEFSKY J: Muscle-specific Pparg deletion causes insulin resistance. Nat Med 9: 1491-1497, 2003.
44. HIRABARA SM, CURI R, MAECHLER P: Saturated fatty acid-induced insulin resistance is associated with mitochondrial dysfunction in skeletal muscle cells. J Cell Physiol 222: 187-194, 2010.
45. HOEHN KL, SALMON AB, HOHNEN-BEHRENS C, TURNER N, HOY AJ, MAGHZAL GJ, STOCKER R, VAN REMMEN H, KRAEGEN EW, COONEY GJ, RICHARDSON AR, JAMES DE: Insulin resistance is a cellular antioxidant defense mechanism. Proc Natl Acad Sci U S A 106: 17787-17792, 2009.
46. HOEKS J, VAN HERPEN NA, MENSINK M, MOONEN-KORNIPS E, VAN BEURDEN D, HESSELINK MK, SCHRAUWEN P: Prolonged fasting identifies skeletal muscle mitochondrial dysfunction as consequence rather than cause of human insulin resistance. Diabetes 59: 2117-2125, 2010.
47. HOEKS J, WILDE JD, HULSHOF MF, BERG SA, SCHAART G, DIJK KW, SMIT E, MARIMAN EC: High fat dietinduced changes in mouse muscle mitochondrial phospholipids do not impair mitochondrial respiration despite insulin resistance. PLoS One 6: e27274, 2011.
48. HU S, YAO J, HOWE AA, MENKE BM, SIVITZ WI, SPECTOR AA, NORRIS AW: Peroxisome proliferatoractivated receptor γ decouples fatty acid uptake from lipid inhibition of insulin signaling in skeletal muscle. Mol Endocrinol 26: 977-988, 2012.
49. ITANI SI, RUDERMAN NB, SCHMIEDER F, BODEN G: Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes 51: 2005-2011, 2002.
50. JAMES AM, COLLINS Y, LOGAN A, MURPHY MP: Mitochondrial oxidative stress and the metabolic syndrome. Trends Endocrinol Metab 23: 429-434, 2012.
51. KARPE F, DICKMANN JR, FRAYN KN: Fatty acids, obesity, and insulin resistance: time for a reevaluation. Diabetes 60: 2441-2449, 2011.
52. KELLEY DE, HE J, MENSHIKOVA EV, RITOV VB: Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 51: 2944-2950, 2002.
53. KIEN CL, EVERINGHAM KI, D STEVENS R, FUKAGAWA NK, MUOIO DM: Short-term effects of dietary fatty acids on muscle lipid composition and serum acylcarnitine profile in human subjects. Obesity (Silver Spring) 19: 305-311, 2011.
54. KIM JY, HICKNER RC, CORTRIGHT RL, DOHM GL, HOUMARD JA: Lipid oxidation is reduced in obese human skeletal muscle. Am J Physiol Endocrinol Metab 279: E1039-E1044, 2000.
55. KLIEWER SA, SUNDSETH SS, JONES SA, BROWN PJ, WISELY GB, KOBLE CS, DEVCHAND P, WAHLI W, WILLSON TM, LENHARD JM, LEHMANN JM: Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. Proc Natl Acad Sci U S A 94: 4318-4323, 1997.
56. KOVES TR, USSHER JR, NOLAND RC, SLENTZ D, MOSEDALE M, ILKAYEVA O, BAIN J, STEVENS R, DYCK JR, NEWGARD CB, LOPASCHUK GD, MUOIO DM: Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab 7: 45-56, 2008.
57. KRÄMER DK, AL-KHALILI L, PERRINI S, SKOGSBERG J, WRETENBERG P, KANNISTO K, WALLBERGHENRIKSSON H, EHRENBORG E, ZIERATH JR, KROOK A: Direct activation of glucose transport in primary human myotubes after activation of peroxisome proliferator-activated receptor delta. Diabetes 54:1157-1163, 2005.
58. KRSSAK M, FALK PETERSEN K, DRESNER A, DIPIETRO L, VOGEL SM, ROTHMAN DL, RODEN M, SHULMAN GI: Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study. Diabetologia 42: 113-116, 1999.
59. LAM YY, HATZINIKOLAS G, WEIR JM, JANOVSKÁ A, MCAINCH AJ, GAME P, MEIKLE PJ, WITTERT GA:Insulin-stimulated glucose uptake and pathways regulating energy metabolism in skeletal muscle cells: the effects of subcutaneous and visceral fat, and long-chain saturated, n-3 and n-6 polyunsaturated fatty acids. Biochim Biophys Acta 1811: 468-475, 2011.
60. LAMBERTUCCI RH, HIRABARA SM, SILVEIRA LR, LEVADA-PIRES AC, CURI R, PITHON-CURI TC:Palmitate increases superoxide production through mitochondrial electron transport chain and NADPH oxidase activity in skeletal muscle cells. J Cell Physiol 216: 796-804, 2008.
61. LEE JS, PINNAMANENI SK, EO SJ, CHO IH, PYO JH, KIM CK, SINCLAIR AJ, FEBBRAIO MA, WATT MJ:Saturated, but not n-6 polyunsaturated, fatty acids induce insulin resistance: role of intramuscular accumulation of lipid metabolites. J Appl Physiol (1985) 100: 1467-1474, 2006.
62. LEFORT N, GLANCY B, BOWEN B, WILLIS WT, BAILOWITZ Z, DE FILIPPIS EA, BROPHY C, MEYER C, HØJLUND K, YI Z, MANDARINO LJ: Increased reactive oxygen species production and lower abundance of complex I subunits and carnitine palmitoyltransferase 1B protein despite normal mitochondrial respiration in insulin-resistant human skeletal muscle. Diabetes 59: 2444-2452, 2010.
63. LIONETTI L, MOLLICA MP, SICA R, DONIZZETTI I, GIFUNI G, PIGNALOSA A, CAVALIERE G, PUTTI R:Differential effects of high-fish oil and high-lard diets on cells and cytokines involved in the inflammatory process in rat insulin-sensitive tissues. Int J Mol Sci 15: 3040-3063, 2014.
64. LISTENBERGER LL, HAN X, LEWIS SE, CASES S, FARESE RV Jr, ORY DS, SCHAFFER JE: Triglyceride accumulation protects against fatty acid-induced lipotoxicity. Proc Natl Acad Sci U S A 100: 3077-3082, 2003.
65. LIU L, ZHANG Y, CHEN N, SHI X, TSANG B, YU YH: Upregulation of myocellular DGAT1 augments triglyceride synthesis in skeletal muscle and protects against fat-induced insulin resistance. J Clin Invest 117: 1679-1689, 2007.
66. LOTTENBERG AM, AFONSO MDS, LAVRADOR MSF, MACHADO RM, NAKANDAKARE ER: The role of dietary fatty acids in the pathology of metabolic syndrome. J Nutr Biochem 23: 1027-1040, 2012.
67. LOVEJOY JC, SMITH SR, CHAMPAGNE CM, MOST MM, LEFEVRE M, DELANY JP, DENKINS YM, ROOD JC, VELDHUIS J, BRAY GA: Effects of diets enriched in saturated (palmitic), monounsaturated (oleic), or trans (elaidic) fatty acids on insulin sensitivity and substrate oxidation in healthy adults. Diabetes Care 25: 1283-1288, 2002.
68. LOWELL BB, SHULMAN GI: Mitochondrial dysfunction and type 2 diabetes. Science 307: 384-387, 2005.
69. MIWA H: High-performance liquid chromatographic determination of free fatty acids and esterified fatty acids in biological materials as their 2-nitrophenylhydrazides. Anal Chim Acta 465: 237-255, 2002.
70. MOOTHA VK, LINDGREN CM, ERIKSSON KF, SUBRAMANIAN A, SIHAG S, LEHAR J, PUIGSERVER P, CARLSSON E, RIDDERSTRÅLE M, LAURILA E, HOUSTIS N, DALY MJ, PATTERSON N, MESIROV JP, GOLUB TR, TAMAYO P, SPIEGELMAN B, LANDER ES, HIRSCHHORN JN, ALTSHULER D, GROOP LC: PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34: 267-273, 2003.
71. MORINO K, PETERSEN KF, SHULMAN GI: Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction. Diabetes 55 (Suppl 2): S9-S15, 2006.
72. MORO C, BAJPEYI S, SMITH SR: Determinants of intramyocellular triglyceride turnover: implications for insulin sensitivity. Am J Physiol Endocrinol Metab 294: E203-E213, 2008.
73. MUOIO DM, MACLEAN PS, LANG DB, LI S, HOUMARD JA, WAY JM, WINEGAR DA, CORTON JC, DOHM GL, KRAUS WE: Fatty acid homeostasis and induction of lipid regulatory genes in skeletal muscles of peroxisome proliferator-activated receptor (PPAR) alpha knock-out mice. Evidence for compensatory regulation by PPAR delta. J Biol Chem 277: 26089-26097, 2002.
74. MUOIO DM, NEUFER PD: Lipid-induced mitochondrial stress and insulin action in muscle. Cell Metab 15: 595-605, 2012.
75. NAKAMURA MT, YUDELL BE, LOOR JJ: Regulation of energy metabolism by long-chain fatty acids. Prog Lipid Res 53: 124-144, 2014.
76. NIELSEN S, GUO Z, JOHNSON CM, HENSRUD DD, JENSEN MD: Splanchnic lipolysis in human obesity. J Clin Invest 113: 1582-1588, 2004.
77. PAN DA, LILLIOJA S, KRIKETOS AD, MILNER MR, BAUR LA, BOGARDUS C, JENKINS AB, STORLIEN LH:Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes 46: 983-988, 1997.
78. PATKOVÁ J, ANDEL M, TRNKA J: Palmitate-induced cell death and mitochondrial respiratory dysfunction in myoblasts are not prevented by mitochondria-targeted antioxidants. Cell Physiol Biochem 33: 1439-1451, 2014.
79. PATTI ME, BUTTE AJ, CRUNKHORN S, CUSI K, BERRIA R, KASHYAP S, MIYAZAKI Y, KOHANE I, COSTELLO M, SACCONE R, LANDAKER EJ, GOLDFINE AB, MUN E, DEFRONZO R, FINLAYSON J, KAHN CR, MANDARINO LJ: Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proc Natl Acad Sci U S A 100: 8466-8471, 2003.
80. PETERSEN KF, BEFROY D, DUFOUR S, DZIURA J, ARIYAN C, ROTHMAN DL, DIPIETRO L, CLINE GW, SHULMAN GI: Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 300:1140-1142, 2003.
81. PETERSEN KF, DUFOUR S, BEFROY D, GARCIA R, SHULMAN GI: Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 350: 664-671, 2004.
82. PICKERSGILL L, LITHERLAND GJ, GREENBERG AS, WALKER M, YEAMAN SJ: Key role for ceramides in mediating insulin resistance in human muscle cells. J Biol Chem 282: 12583-12589, 2007.
83. PIMENTA AS, GAIDHU MP, HABIB S, SO M, FEDIUC S, MIRPOURIAN M, MUSHEEV M, CURI R, CEDDIA RB: Prolonged exposure to palmitate impairs fatty acid oxidation despite activation of AMP-activated protein kinase in skeletal muscle cells. J Cell Physiol 217: 478-485, 2008.
84. POSPISILIK JA, KNAUF C, JOZA N, BENIT P, ORTHOFER M, CANI PD, EBERSBERGER I, NAKASHIMA T, SARAO R, NEELY G, ESTERBAUER H, KOZLOV A, KAHN CR, KROEMER G, RUSTIN P, BURCELIN R, PENNINGER JM: Targeted deletion of AIF decreases mitochondrial oxidative phosphorylation and protects from obesity and diabetes. Cell 131: 476-491, 2007.
85. RANDLE PJ, GARLAND PB, HALES CN, NEWSHOLME EA: The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 281: 785-789, 1963.
86. RICCARDI G, GIACCO R, RIVELLESE AA: Dietary fat, insulin sensitivity and the metabolic syndrome. Clin Nutr 23: 447-456, 2004.
87. RITOV VB, MENSHIKOVA EV, HE J, FERRELL RE, GOODPASTER BH, KELLEY DE: Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes. Diabetes 54: 8-14, 2005.
88. RITOV VB, MENSHIKOVA EV, AZUMA K, WOOD R, TOLEDO FG, GOODPASTER BH, RUDERMAN NB, KELLEY DE: Deficiency of electron transport chain in human skeletal muscle mitochondria in type 2 diabetes mellitus and obesity. Am J Physiol Endocrinol Metab 298: E49-E58, 2010.
89. ROUST LR, JENSEN MD: Postprandial free fatty acid kinetics are abnormal in upper body obesity. Diabetes 42: 1567-1573, 1993.
90. SALVADÓ L, COLL T, GÓMEZ-FOIX AM, SALMERÓN E, BARROSO E, PALOMER X, VÁZQUEZ-CARRERA M: Oleate prevents saturated-fatty-acid-induced ER stress, inflammation and insulin resistance in skeletal muscle cells through an AMPK-dependent mechanism. Diabetologia 56: 1372-1382, 2013.
91. SANTOMAURO AT, BODEN G, SILVA ME, ROCHA DM, SANTOS RF, URSICH MJ, STRASSMANN PG, WAJCHENBERG BL: Overnight lowering of free fatty acids with Acipimox improves insulin resistance and glucose tolerance in obese diabetic and nondiabetic subjects. Diabetes 48: 1836-1841, 1999.
92. SCHAFFER JE: Lipotoxicity: when tissues overeat. Curr Opin Lipidol 14: 281-287, 2003.
93. SCHENK S, HOROWITZ JF: Acute exercise increases triglyceride synthesis in skeletal muscle and prevents fatty acidinduced insulin resistance. J Clin Invest 117: 1690-1698, 2007.
94. SCHIEBER M, CHANDEL NS: ROS function in redox signaling and oxidative stress. Curr Biol 24: R453-R462, 2014.
95. SCHULER M, ALI F, CHAMBON C, DUTEIL D, BORNERT JM, TARDIVEL A, DESVERGNE B, WAHLI W, CHAMBON P, METZGER D: PGC1alpha expression is controlled in skeletal muscles by PPARbeta, whose ablation results in fiber-type switching, obesity, and type 2 diabetes. Cell Metab 4: 407-414, 2006.
96. SEIFERT EL, ESTEY C, XUAN JY, HARPER ME: Electron transport chain-dependent and -independent mechanisms of mitochondrial H2O2 emission during long-chain fatty acid oxidation. J Biol Chem 285: 5748-5758, 2010.
97. SENN JJ: Toll-like receptor-2 is essential for the development of palmitate-induced insulin resistance in myotubes. J Biol Chem 281: 26865-26875, 2006.
98. SHULMAN GI: Cellular mechanisms of insulin resistance. J Clin Invest 106: 171-176, 2000.
99. SPARKS LM, XIE H, KOZA RA, MYNATT R, HULVER MW, BRAY GA, SMITH SR: A high-fat diet coordinately downregulates genes required for mitochondrial oxidative phosphorylation in skeletal muscle. Diabetes 54:1926-1933, 2005.
100. STORLIEN LH, JENKINS AB, CHISHOLM DJ, PASCOE WS, KHOURI S, KRAEGEN EW: Influence of dietary fat composition on development of insulin resistance in rats. Relationship to muscle triglyceride and omega-3 fatty acids in muscle phospholipid. Diabetes 40: 280-289, 1991.
101. SZENDROEDI J, YOSHIMURA T, PHIELIX E, KOLIAKI C, MARCUCCI M, ZHANG D, JELENIK T, MÜLLER J, HERDER C, NOWOTNY P, SHULMAN GI, RODEN M: Role of diacylglycerol activation of PKCθ in lipidinduced muscle insulin resistance in humans. Proc Natl Acad Sci U S A 111: 9597-9602, 2014.
102. TANAKA T, YAMAMOTO J, IWASAKI S, ASABA H, HAMURA H, IKEDA Y, WATANABE M, MAGOORI K, IOKA RX, TACHIBANA K, WATANABE Y, UCHIYAMA Y, SUMI K, IGUCHI H, ITO S, DOI T, HAMAKUBO T, NAITO M, AUWERX J, YANAGISAWA M, KODAMA T, SAKAI J: Activation of peroxisome proliferator-activated receptor delta induces fatty acid beta-oxidation in skeletal muscle and attenuates metabolic syndrome. Proc Natl Acad Sci U S A 100: 15924-15929, 2003.
103. TURNER N, BRUCE CR, BEALE SM, HOEHN KL, SO T, ROLPH MS, COONEY GJ: Excess lipid availability increases mitochondrial fatty acid oxidative capacity in muscle: evidence against a role for reduced fatty acid oxidation in lipid-induced insulin resistance in rodents. Diabetes 56: 2085-2092, 2007.
104. TURNER N, KOWALSKI GM, LESLIE SJ, RISIS S, YANG C, LEE-YOUNG RS, BABB JR, MEIKLE PJ, LANCASTER GI, HENSTRIDGE DC, WHITE PJ, KRAEGEN EW, MARETTE A, COONEY GJ, FEBBRAIO MA, BRUCE CR: Distinct patterns of tissue-specific lipid accumulation during the induction of insulin resistance in mice by high-fat feeding. Diabetologia 56: 1638-1648, 2013.
105. TURNER N, COONEY GJ, KRAEGEN EW, BRUCE CR: Fatty acid metabolism, energy expenditure and insulin resistance in muscle. J Endocrinol 220: T61-T79, 2014.
106. TURPIN SM, LANCASTER GI, DARBY I, FEBBRAIO MA, WATT MJ: Apoptosis in skeletal muscle myotubes is induced by ceramides and is positively related to insulin resistance. Am J Physiol Endocrinol Metab 291:E1341-E1350, 2006.
107. VESSBY B, TENGBLAD S, LITHELL H: Insulin sensitivity is related to the fatty acid composition of serum lipids and skeletal muscle phospholipids in 70-year-old men. Diabetologia 37: 1044-1050, 1994.
108. VESSBY B, UUSITUPA M, HERMANSEN K, RICCARDI G, RIVELLESE AA, TAPSELL LC, NÄLSÉN C, BERGLUND L, LOUHERANTA A, RASMUSSEN BM, CALVERT GD, MAFFETONE A, PEDERSEN E, GUSTAFSSON IB, STORLIEN LH: Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: The KANWU Study. Diabetologia 44: 312-319, 2001.
109. WESSELS B, CIAPAITE J, VAN DEN BROEK NMA, HOUTEN SM, NICOLAY K, PROMPERS JJ: Pioglitazone treatment restores in vivo muscle oxidative capacity in a rat model of diabetes. Diabetes Obes Metab 17: 52-60, 2015.
110. YUZEFOVYCH L, WILSON G, RACHEK L: Different effects of oleate vs. palmitate on mitochondrial function, apoptosis, and insulin signaling in L6 skeletal muscle cells: role of oxidative stress. Am J Physiol Endocrinol Metab 299: E1096-E1105, 2010.
111. YUZEFOVYCH LV, SOLODUSHKO VA, WILSON GL, RACHEK LI: Protection from palmitate-induced mitochondrial DNA damage prevents from mitochondrial oxidative stress, mitochondrial dysfunction, apoptosis, and impaired insulin signaling in rat l6 skeletal muscle cells. Endocrinology 153: 92-100, 2012.